As SUS become prevalent in the biologics industry, the question of safety becomes increasingly important.
Andreas Nixdorf
Advertisement
Andreas Nixdorf is business development manager Extractables & Leachables Testing at SGS.
Articles by Andreas Nixdorf
Advertisement
Latest Updated Articles
Extractables and Leachables: Determining Risk in Single-Use SystemsPublished: June 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
